ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000231663.1	ABT-263 (navitoclax)	Sarcoma	0.039395629	Resistant
ENSG00000231663.1	ABT-263 (navitoclax)	Esophageal cancer	0.014468904	Sensitive